HTB

Other news

Europe moves to speed up approval of new drugs

Deal allows developing countries free access to journals

African advocacy groups call for dismissal of USAID director Natsios after ‘racist comments’

Thai officials call for cancellation of AIDS ‘miracle cure’ distribution amid controversy

Canada Reverses ban on entry of HIV-positive immigrants

Bristol-Myers Squibb agrees to purchase DuPont’s drug business

NEJM commemorates 20 years of AIDS with early-release retrospective

New York’s Beth Israel Hospital making post-exposure HIV treatment available to general public

The relationships between ethnicity, sex, risk group,and virus load in HIV-1 antiretroviral-naive patients

HIV drug resistance is increasing in the UK

FDA warning to manufacturers of antiretrovirals over misleading advertising

Mbeki questions validity of HIV testing

Aerobic exercise benefits HIV-positive adults

Whey proteins help replenish glutathione levels

Therapeutic drug monitoring: ready For clinical practice?

Expert column: recent developments and current issues in HIV-related renal disease

HPV-induced anal dysplasia: what do We know and what can we do about it?

Company lobbyist joins Oxfam campaign for cheaper HIV drugs

John Le Carre describes drug industry’s ‘crimes of unbridled capitalism’ in Nation column

College students protest university patents on AIDS drugs

IAPAC to launch HIV training, certification program for developing world physicians

South African panel recognizes HIV as cause of AIDS

AIDS-related abdominal disease does not increase surgery risk in AIDS patients

Protease inhibitor use not linked to atherosclerosis in middle-aged HIV patients

Pain common among HIV-positive individuals

Manifestations of syphilis similar in HIV positive and HIV negative subjects

HAART improves subcortical functioning in cognitively impaired HIV patients

Link documented between problem drinking, noncompliance with HIV treatment

Stress, anger bad for HIV patients’ immune system

Grief counselling may lower HIV viral load

UK to start trials of new cervical cancer vaccine

Mortality from liver disease increasing in HIV-positive patients

Alpha-1 antitrypsin, a natural protein may block HIV

Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa

Influenza vaccination does not accelerate HIV infection

Perceived pain in AIDS patients often linked to anxiety, depression

New report on depression in HIV patients

Website for ESPRIT IL-2 study

FDA meeting on approving immune therapies: background and comment

HIV seroprevalence by anonymous testing in patients with mycobacterium tuberculosis and in tuberculosis contacts

HIV-1 Immunogen fails to extend HIV progression-free survival

Scrub typhus: infection reduces viral load in some patients

Immunorestitution disease

The prevalence of hypogonadism in HIV positive patients receiving HAART

$1bn drug deal creates debt for “tomorrow’s AIDS orphans”

Hit HIV-1 hard, but only when necessary

Obiturary: Kiyoshi Kuromiya, 1943-2000

What is Armenicum?

Drug companies fail to conduct necessary post-marketing studies

A view from the lab: interview with Professor Clive Loveday

French National Drug Agency re-commends use of IL-2 if HAART does not lead to an increase in CD4 count to greater than 200 cells/mm3

Public Health Service (US) releases updated guidelines for treatment of HIV positive pregnant women (April 2000)

French Health Authority approves enteric coated ddI

U.S. FDA approves film-coated nelfinavir mesylate (Viraceptâ„¢)

St John’s Wort

Post navigation